07Nov

Cytox appoints new CCO

cytox-logo

Oxford and Manchester, UK – Cytox, a precision medicine company focused on developing solutions to identify individuals most at risk for developing Alzheimer's disease and dementia, today announced the appointment of Antony Hill as Chief Commercial Officer.

“We are pleased to welcome Tony Hill to the Cytox team,’ commented Cytox CEO, Dr Richard Pither, He joins us at a very exciting time for Cytox. This year we announced several important new collaborations and funding from Innovate UK and presented results on our recent advancements at all the major conferences, including how we identify Alzheimer’s disease risk in ApoE3 homozygote individuals, and also identify those individuals most likely to progress from mild cognitive impairment to Alzheimer’s.

“Tony has been involved in the diagnostics and molecular life sciences industry for 30 years, with senior roles in sales and marketing in international diagnostics and molecular life science companies including TwistDx Ltd (part of Abbott Diagnostics), Diasorin Molecular, Innogenetics and Sigma-Aldrich. He will greatly strengthen our management team and enable us to progress our partnerships and develop our clinical products.”

Related

Safe, Easy UN3373 Sample Transport

The latest addition to the SpeciSafe® range, from Alpha Laboratories, is a pack to enclose two pae...

Read More >

SpeeDx and Diagen sign new distribution agreement for Scandinavia

SYDNEY, AUSTRALIA – (Sept 19, 2017). SpeeDx Pty, Ltd. has announced a distribution agreement with D...

Read More >

DiaSorin and Tecan to collaborate in new platform development

DiaSorin and Tecan Group have announced that they have agreed to collaborate in a development under ...

Read More >

RPS Diagnostics partners with Atomo Diagnostics to develop next generation Febridx blood tests for Antibiotic Stewardship in the Outpatient setting

Sarasota, Florida and Sydney, Australia (February 20, 2018) – United States biotechnology company, ...

Read More >

DEMAND FOR GENETIC TESTING DRIVES GROWTH FOR AWARD WINNING ELUCIGENE DIAGNOSTICS

30 percent growth and innovation products wins Manchester company BVCA award. Having the right te...

Read More >